What is the presentation of Wolff-Parkinson-White (WPW) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Presentation of Wolff-Parkinson-White Syndrome

Wolff-Parkinson-White syndrome presents with characteristic ECG findings of ventricular pre-excitation (delta wave, short PR interval <0.12 seconds, widened QRS >0.12 seconds) and may be either asymptomatic or symptomatic with tachyarrhythmias, palpitations, syncope, or in rare cases, sudden cardiac death. 1, 2

Electrocardiographic Features (Diagnostic Hallmarks)

The ECG diagnosis requires all of the following features present simultaneously:

  • Delta wave - slurring of the initial QRS upstroke due to ventricular pre-excitation via the accessory pathway, which is the defining feature that must be present 3, 2
  • PR interval <0.12 seconds - shortened due to bypass of the AV node 2, 4
  • QRS complex widening >0.12 seconds - total duration prolonged from fusion of pre-excited and normally conducted ventricular activation 2, 4
  • Secondary repolarization changes - ST segment and T wave changes directed opposite (discordant) to the major delta wave and QRS complex 2

Important caveat: A short PR interval alone without delta waves does not constitute WPW and may represent normal variant conduction or enhanced AV nodal conduction 3

Clinical Presentations: Asymptomatic vs Symptomatic

Asymptomatic Presentation (WPW Pattern)

  • Approximately 50% of patients with the WPW ECG pattern remain asymptomatic throughout their lives, discovered incidentally on routine ECG or during pre-participation sports screening 1
  • The prevalence of asymptomatic WPW pattern is 0.1-0.3% in the general population 1, 5
  • Critical warning: Sudden cardiac death may be the first manifestation in approximately 50% of cardiac arrest cases in WPW patients, occurring even in previously asymptomatic individuals 3, 4
  • Annual risk of sudden death in asymptomatic patients is low (0.15-0.2%) but not zero 6

Symptomatic Presentation (WPW Syndrome)

When symptoms occur, they are secondary to tachyarrhythmias and include:

  • Palpitations - the most common symptom, representing episodes of supraventricular tachycardia occurring in the majority of symptomatic patients 3, 2
  • Syncope or presyncope - particularly concerning symptoms indicating rapid conduction over the accessory pathway with risk of sudden death 6, 3, 4
  • Dizziness during tachyarrhythmia episodes 3
  • Chest pain during arrhythmic episodes, though less common 3
  • Shortness of breath indicating hemodynamic compromise during tachyarrhythmias 3
  • Fatigue, especially during activities like driving (57% of patients with supraventricular tachycardia experience episodes while driving) 3

Arrhythmic Manifestations

The tachyarrhythmias encountered in WPW patients include:

  • Atrioventricular reciprocating tachycardia (AVRT) - accounts for 95% of reentrant tachycardias in WPW, typically narrow QRS complex with anterograde conduction through the AV node and retrograde through the accessory pathway 3, 7, 2
  • Pre-excited atrial fibrillation - the most dangerous arrhythmia, occurring in 0-9% of asymptomatic patients and up to one-third of all WPW patients, characterized by wide QRS complexes with irregular rhythm 1, 3, 5
  • Atrial flutter - less common but can conduct rapidly over the accessory pathway 2
  • Ventricular fibrillation - occurs in 0-2% of asymptomatic patients when atrial fibrillation degenerates due to very rapid ventricular rates via the accessory pathway 1, 3

High-Risk Features Predicting Sudden Death

Specific characteristics identify patients at increased risk for life-threatening events:

  • Shortest pre-excited RR interval <250 ms during atrial fibrillation - the strongest predictor of sudden cardiac death risk 1, 6, 3
  • History of symptomatic tachycardia - increases sudden death risk, with symptomatic patients having 2.2% annual risk versus 0.15-0.2% in asymptomatic patients 1, 6
  • Multiple accessory pathways - associated with higher risk 1, 3
  • Posteroseptal pathway location - identified as higher risk 1
  • Young age - highest risk appears in the first two decades of life, with sudden death occurring more frequently in exercising individuals 3, 4

Low-Risk Indicators

Certain findings suggest benign accessory pathway properties:

  • Intermittent pre-excitation on resting ECG or ambulatory monitoring indicates low risk with 90% positive predictive value 1, 3
  • Abrupt loss of pre-excitation during exercise testing suggests long accessory pathway refractory period and low sudden death risk 1, 3

Associated Structural Heart Disease

WPW may occur with concomitant cardiac abnormalities requiring evaluation:

  • Ebstein's anomaly - congenital heart defect associated with increased risk 3, 5
  • Hypertrophic cardiomyopathy 3
  • PRKAG2-related familial WPW with glycogen storage cardiomyopathy 3
  • Most patients (93-95%) have structurally normal hearts 1, 5

Special Population Considerations

Athletes

  • WPW accounts for at least 1% of sudden death in athletes 4
  • Risk of lethal arrhythmia appears higher in asymptomatic children than adults 4
  • Sudden cardiac death is often the sentinel event in athletic individuals 4

Pediatric Patients

  • Ventricular fibrillation occurs predominantly in children (0-2% of asymptomatic patients) 3
  • Higher risk of sudden death in the first two decades of life 3

Common Diagnostic Pitfalls

  • Left lateral accessory pathways may show minimal delta waves due to fusion with normal AV nodal conduction, potentially appearing as intermittent pre-excitation when actually continuously present 3
  • Careful ECG inspection is necessary to ensure delta waves are truly absent rather than subtle 3
  • Short PR interval without delta waves requires evaluation for other conditions like Lown-Ganong-Levine syndrome only if recurrent unexplained tachyarrhythmias occur 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Monitoring and Management of Wolff-Parkinson-White Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Approach for Wolff-Parkinson-White (WPW) Syndrome in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current management of the Wolff-Parkinson-White syndrome.

Journal of cardiac surgery, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.